Schwed JS - Search Results

1

Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H₃ R Antagonism for Neurodegenerative Diseases.

Bautista-Aguilera ÓM, Hagenow S, Palomino-Antolin A, Farré-Alins V, Ismaili L, Joffrin PL, Jimeno ML, Soukup O, Janočková J, Kalinowsky L, Proschak E, Iriepa I, Moraleda I, Schwed JS, Romero Martínez A, López-Muñoz F, Chioua M, Egea J, Ramsay RR, Marco-Contelles J, Stark H. Bautista-Aguilera ÓM, et al. Among authors: schwed js. Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12765-12769. doi: 10.1002/anie.201706072. Epub 2017 Sep 1. Angew Chem Int Ed Engl. 2017. PMID: 28861918

2

Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands.

Sadek B, Schreeb A, Schwed JS, Weizel L, Stark H. Sadek B, et al. Among authors: schwed js. Drug Des Devel Ther. 2014 Sep 19;8:1499-513. doi: 10.2147/DDDT.S66179. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25278747 Free PMC article.

3

Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.

Sadek B, Schwed JS, Subramanian D, Weizel L, Walter M, Adem A, Stark H. Sadek B, et al. Among authors: schwed js. Eur J Med Chem. 2014 Apr 22;77:269-79. doi: 10.1016/j.ejmech.2014.03.014. Epub 2014 Mar 6. Eur J Med Chem. 2014. PMID: 24650714

4

Anticonvulsant effects of isomeric nonimidazole histamine H₃ receptor antagonists.

Sadek B, Saad A, Schwed JS, Weizel L, Walter M, Stark H. Sadek B, et al. Among authors: schwed js. Drug Des Devel Ther. 2016 Nov 7;10:3633-3651. doi: 10.2147/DDDT.S114147. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27853355 Free PMC article.

5

Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness.

Wingen K, Schwed JS, Isensee K, Weizel L, Zivković A, Odadzic D, Stark H. Wingen K, et al. Among authors: schwed js. Bioorg Med Chem Lett. 2014 May 15;24(10):2236-9. doi: 10.1016/j.bmcl.2014.03.098. Epub 2014 Apr 8. Bioorg Med Chem Lett. 2014. PMID: 24745967

6

Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.

Lipani L, Odadzic D, Weizel L, Schwed JS, Sadek B, Stark H. Lipani L, et al. Among authors: schwed js. Eur J Med Chem. 2014 Oct 30;86:578-88. doi: 10.1016/j.ejmech.2014.09.011. Epub 2014 Sep 6. Eur J Med Chem. 2014. PMID: 25218907

7

Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand.

Tomasch M, Schwed JS, Paulke A, Stark H. Tomasch M, et al. Among authors: schwed js. ACS Med Chem Lett. 2012 Dec 12;4(2):269-73. doi: 10.1021/ml300383n. eCollection 2013 Feb 14. ACS Med Chem Lett. 2012. PMID: 24900647 Free PMC article.

8

Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H₃ receptor antagonist ST-1283.

Bahi A, Schwed JS, Walter M, Stark H, Sadek B. Bahi A, et al. Among authors: schwed js. Drug Des Devel Ther. 2014 May 28;8:627-37. doi: 10.2147/DDDT.S63088. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24920886 Free PMC article.

9

Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents.

Kuder K, Łażewska D, Latacz G, Schwed JS, Karcz T, Stark H, Karolak-Wojciechowska J, Kieć-Kononowicz K. Kuder K, et al. Among authors: schwed js. Bioorg Med Chem. 2016 Jan 15;24(2):53-72. doi: 10.1016/j.bmc.2015.11.021. Epub 2015 Dec 2. Bioorg Med Chem. 2016. PMID: 26690914

10

Dopamine D3 receptor agonists as pharmacological tools.

Kassel S, Schwed JS, Stark H. Kassel S, et al. Among authors: schwed js. Eur Neuropsychopharmacol. 2015 Sep;25(9):1480-99. doi: 10.1016/j.euroneuro.2014.11.005. Epub 2014 Nov 15. Eur Neuropsychopharmacol. 2015. PMID: 25498414 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page